Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Import of drugs in...

    Import of drugs in India: Center adds two more ports, Releases Gazette Notification

    Farhat NasimWritten by Farhat Nasim Published On 2019-01-13T09:33:03+05:30  |  Updated On 19 Dec 2022 5:31 PM IST
    Import of drugs in India: Center adds two more ports, Releases Gazette Notification

    New Delhi: An upsurge in the import of drugs is likely to be seen as the government has recently informed about the addition of two new ports for this purpose namely, Kamrajar Port and Mundra Port. The ports would enable import of drugs by sea into India.


    To this effect the Ministry of health and Family Welfare took out a gazetted notification announcing the amendments to the relevant sections in the Drugs and Cosmetics Rules, 1945

    These amendments are called Drugs and Cosmetics (Second Amendment) Rules, 2019 which will come into force on the date of their publication in the Official Gazette that is 10th January, 2019. Amendments in the Drugs and Cosmetics Rules, 1945 have been made wherein the addition of words in Rule 43A has been made, effective from January 10, 2019.


    Rule 43A states that no drug shall be imported into India except through one of the following places, namely:




    • Ferozepore Cantonment and Amritsar Railway Stations: In respect of drugs imported by rail across the frontier with Pakistan.

    • Ranaghat, Bongaon and Mohiassan Railways Stations: In respect of drugs imported by rail across the frontier with Bangladesh.

    • Petrapole Road in West Bengal, Sutarkandi in Assam, Old Raghna Bazar and Agartala in Tripura: In respect of drugs imported by Road from Bangladesh.

    • Raxaul: In respect of drugs imported by road and railway lines connecting Raxaul in India and Birganj in Nepal

    • Chennai, Kolkata, Mumbai, Cochin, Nhava Sheva, Kandla and Inland Container Depots at Tuglakabad and Patparganj in Delhi and Tuticorin in Tamil Nadu and Marmugao port in Goa and Visakhapatnam in Andhra Pradesh: In respect of drugs imported by sea into India.

    • Chennai, Kolkata, Mumbai, Delhi, Ahmedabad, Hyderabad, Goa, Bengaluru and Visakhapatnam: In respect of drugs imported by air into India.


    The central government after consultation with the Drugs Technical Advisory Board has substituted the word "Tuticorin" with "Tuticorin and Kamrajar Port" in the Drugs and Cosmetics Rules, 1945, in rule 43A; and for the word "Gandhinagar", the words "Gandhinagar and Mundra Port" is substituted.


    In this regard, the Government had earlier issued another notifications inviting objections and suggestions from persons likely to be affected. Copies of the Official Gazette were made available to the public on the 23rd of October, 2018. However, no objections or suggestions were received from the public on the said rules for consideration by the Central Government.


    Also Read: Drugs and Cosmetics Rules, 1945 being amended: AYUSH Minster

    drug importdrugsDrugs and Cosmetic RulesDrugs and Cosmetics Rules 1945GandhinagarGandhinagar and Mundra Portgazette notificationgovt of indiaindian govtmedicinespharmapharma newspharma news indiaPharmaceuticalsrule 43aTuticorinTuticorin and Kamrajar Port

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok